News and events for ARCH Precision Manufacturing

“We are excited to announce the acquisition of RIC, as this acquisition broadens our custom tool offerings as we continue to expand ARCH’s custom tooling solutions through ‘ARCH Specials.’ RIC has over 55 years’ experience providing specialty tooling and regrinds, and brings an experienced and highly technical senior management team that places a high degree of emphasis on engineering solutions and design,” commented Jeff Cederstrom, ARCH Global Precision Divisional President of Cutting Tools. “We see strong cultural and strategic alignment between RIC and ARCH, which will result in a smooth transition and immediate opportunities to leverage and expand upon existing customer relationships,” concluded Mr. Cederstrom.

John Lombari, the former owner and President of RIC, commented, “I am pleased to announce the sale of RIC to ARCH Global Precision. When I made the decision to sell my business there were two characteristics in particular that were highly important to me. The first being that the acquirer would have the same high level of respect for my employees that I’ve always had, and secondly, the buyer would be committed to further investment in the business to facilitate our next stage of growth. I developed a relationship with ARCH over the last several years, and after the positive experience I’ve had throughout the sale process, I feel even more assured that ARCH was indeed the ideal buyer.” Mr. Lombari will continue in his current role for the foreseeable future to ensure the successful integration of the business.

“Seabrook represents our 3rd medical acquisition over the past 10 months as we continue to gain critical mass in this end market. This latest acquisition confirms our commitment to building a medical business with vast capabilities, a breadth of product offerings and a diverse customer base. Seabrook strengthens our existing capabilities in the manufacturing of complex single and multi-assembly instruments, in addition to adding a broader range of implants for various types of medical procedures we have not supported in the past,” commented Eli Crotzer, ARCH Global Precision President and Chief Executive Officer. “Seabrook has a highly skilled and experienced management team who we look forward to partnering with during the next stage of growth. Moreover, Seabrook’s current President and CEO, Paul Barck, is assuming the role of Divisional President of ARCH Medical Solutions,” concluded Mr. Crotzer.

Mr. Barck commented, “I am excited to announce the sale of Seabrook to ARCH Global Precision. Having known Eli and ARCH Global Precision for the last several years, it was an easy decision for us to choose ARCH as the best partner for Seabrook given the cultural alignment and commitment to supporting the future growth of Seabrook. Furthermore, I am pleased to accept the role of Divisional President of ARCH Medical Solutions, and I am excited to provide leadership for this important segment within the ARCH organization.”